Raphael Pharmaceutical (RAPH) Free Cash Flow Growth (3y) (2023 - 2025)
Raphael Pharmaceutical (RAPH) Free Cash Flow Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 9.86% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -18.92% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 2.82% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 45.60% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 39.19% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -82.02% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 18.94% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 94.95% |
| 10 | Raphael Pharmaceutical | - | - | - | 29.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.39% |
| Sep 30, 2025 | 51.82% |
| Jun 30, 2025 | 50.54% |
| Mar 31, 2025 | -36.60% |
| Dec 31, 2024 | 55.51% |
| Sep 30, 2024 | 34.21% |
| Jun 30, 2024 | 10.59% |
| Mar 31, 2024 | -10.28% |
| Dec 31, 2023 | 42.71% |